H19 DMR methylation correlates to the progression of esophageal squamous cell carcinoma through IGF2 imprinting pathway

Clinical and Translational Oncology

Volumn 16, Issue 4, 2014, Pages 410-417

  Gao, T ^a   He, B ^a   Pan, Y ^a   Gu, L ^a,b   Chen, L ^a,b   Nie, Z ^a   Xu, Y ^a   Li, R ^a,b   Wang, S ^a  

^a NANJING MEDICAL UNIVERSITY   (China)

^b NANJING NORMAL UNIVERSITY   (China)

Author keywords

ESCC; Expression; H19 CBS; IGF2; LOI; Methylation

Indexed keywords

BISULFITE; GENOMIC DNA; SOMATOMEDIN B; H19 LONG NON-CODING RNA; IGF2 PROTEIN, HUMAN; LONG UNTRANSLATED RNA;

ADULT; AGED; ARTICLE; CANCER GRADING; CANCER GROWTH; CANCER PATIENT; CONTROLLED STUDY; CPG ISLAND; DNA METHYLATION; DNA POLYMORPHISM; ESOPHAGEAL SQUAMOUS CELL CARCINOMA; EXON; FEMALE; GENE SEQUENCE; GENOME IMPRINTING; H19 GENE; HETEROZYGOTE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; METASTASIS; MIDDLE AGED; POLYMERASE CHAIN REACTION; REAL TIME POLYMERASE CHAIN REACTION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR GENE; DISEASE COURSE; ESOPHAGUS TUMOR; GENE EXPRESSION REGULATION; GENETICS; GENOTYPE; METABOLISM; PATHOLOGY; PHYSIOLOGY; SIGNAL TRANSDUCTION; SQUAMOUS CELL CARCINOMA; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, SQUAMOUS CELL; DISEASE PROGRESSION; DNA METHYLATION; ESOPHAGEAL NEOPLASMS; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GENOMIC IMPRINTING; GENOTYPE; HUMANS; IMMUNOHISTOCHEMISTRY; INSULIN-LIKE GROWTH FACTOR II; MALE; MIDDLE AGED; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; REAL-TIME POLYMERASE CHAIN REACTION; RNA, LONG NONCODING; SIGNAL TRANSDUCTION;

EID: 84898602395     PISSN: 1699048X     EISSN: 16993055     Source Type: Journal    
DOI: 10.1007/s12094-013-1098-x     Document Type: Article

References (30)

1. Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer J Clin. 2011;61(2):69-90.
2. Parkin DM, Bray FI, Devesa SS. Cancer burden in the year 2000. The global picture. Eur J Cancer. 2011;37(Suppl 8):S4-66.
3. Luo M, Li Z, Wang W, Zeng Y, Liu Z, Qiu J. Upregulated H19 contributes to bladder cancer cell proliferation by regulating ID2 expression. FEBS J. 2013;280(7):1709-16.
4. Sorin V, Ohana P, Gallula J, Birman T, Matouk I, Hubert A, et al. H19-promoter-targeted therapy combined with gemcitabine in the treatment of pancreatic cancer. ISRN Oncol. 2012;2012:351750.
5. Cui H, Onyango P, Brandenburg S, Wu Y, Hsieh CL, Feinberg AP. Loss of imprinting in colorectal cancer linked to hypomethylation of H19 and IGF2. Cancer Res. 2002;62:6442-6. (Pubitemid 35364103)
6. Murphy SK, Huang Z, Wen Y, Spillman MA, Whitaker RS, Simel LR, et al. Frequent IGF2/H19 domain epigenetic alterations and elevated IGF2 expression in epithelial ovarian cancer. Mol Cancer Res. 2006;4:283-92.
7. Gicquel C, Rossignol S, Cabrol S, Houang M, Steunou V, Barbu V, et al. Epimutation of the telomeric imprinting center region on chromosome 11p15 in Silver-Russell syndrome. Nat Genet. 2005;37:1003-7. (Pubitemid 43086160)
8. Eggermann T, Eggermann K, Schonherr N. Growth retardation versus over-growth: Silver-Russell syndrome is genetically opposite to Beckwith-Wiedemann syndrome. Trends Genet. 2008;24:195-204.
9. Ohlsson R, Hedborg F, Holmgren L, Walsh C, Ekstrom TJ. Overlapping patterns of IGF2 and H19 expression during human development: biallelic IGF2 expression correlates with a lack of H19 expression. Development. 1994;120(2):361-8. (Pubitemid 24042403)
10. Ogawa O, Eccles MR, Szeto J, McNoe LA, Yun K, Maw MA, et al. Relaxation of insulin-like growth factor II gene imprinting implicated in Wilms' tumour. Nature (Lond.). 1993;362:749-51. (Pubitemid 23125978)
11. Mori M, Inoue H, Shiraishi T. Relaxation of insulin-like growth factor 2 gene imprinting in esophageal cancer. Int J Cancer. 1996;68:441-6. (Pubitemid 26414497)
12. Xu W, Fan H, He X, Zhang J, Xie W. LOI of IGF2 is associated with esophageal cancer and linked to methylation status of IGF2 DMR. J Exp Clin Cancer Res. 2006;25:543-7. (Pubitemid 46166769)
13. Cruz-Correa M, Cui H, Giardiello FM. Loss of imprinting of insulin growth factor II gene: a potential heritable bio-marker for colon neoplasia predisposition. Gastroenterology. 2004;126:964-70. (Pubitemid 38451167)
14. Liou JM, Wu MS, Lin JT. Loss of imprinting of insulin-like growth factor II is associated with increased risk of proximal colon cancer. Eur J Cancer. 2007;43:1276-82.
15. Leighton PA, Ingram RS, Eggenschwiler J, Efstratiadis A, Tilghman SM. Disruption of imprinting caused by deletion of the H19 gene region in mice. Nature. 1995;375(6526):34-9.
16. Hark AT, Schoenherr CJ, Katz DJ, Ingram RS, Levorse JM, Tilghman SM. CTCF mediates methylation-sensitive enhancer-blocking activity at the H19/Igf2 locus. Nature. 2000;405(6785):486-89. (Pubitemid 30367428)
17. Cui H, Horon IL, Ohlsson R, Hamilton SR, Feinberg AP. Loss of imprinting in normal tissue of colorectal cancer patients with microsatellite instability. Nat Med. 1998;4:1276-80. (Pubitemid 28512108)
18. Boissonnas CC, Abdalaoui HE, Haelewyn V, Fauque P, Dupont JM, Gut I, et al. Specific epigenetic alterations of IGF2-H19 locus in spermatozoa from infertile men. Eur J Hum Genet. 2010;18(1):73-80.
19. Cui H. Loss of imprinting of IGF2 as an epigenetic marker for the risk of human cancer. Dis Markers. 2007;23:105-12. (Pubitemid 46333644)
20. Yu H, Rohan T. Role of the insulin-like growth factor family in cancer development and progression. J Natl Cancer Inst. 2000;92:1472-89.
21. Furstenberger G, Senn HJ. Insulin-like growth factors and cancer. Lancet Oncol. 2002;2:298-302. (Pubitemid 34546447)
22. Samani AA, Yakar S, LeRoith D, Brodt P. The role of the IGF system in cancer growth and metastasis: overview and recent insights. Endocr Rev. 2007;28:20-47. (Pubitemid 46220849)
23. Sakatani T, Kaneda A, Iacobuzio-Donahue CA. Loss of imprinting of Igf2 alters intestinal maturation and tumori-genesis in mice. Science. 2005;307:1976-8. (Pubitemid 40404709)
24. Ravenel JD, Broman KW, Perlman EJ. Loss of imprinting of insulin-like growth factor-II (IGF2) gene in distinguishing specific biologic subtypes of Wilms tumor. J Natl Cancer Inst. 2001;93:1698-703. (Pubitemid 33130258)
25. Woodson K, Flood A, Green L. Loss of insulin-like growth factor-II imprinting and the presence of screen-detected colorectal adenomas in women. J Natl Cancer Inst. 2004;96:407-10. (Pubitemid 38351303)
26. Feinberg AP, Gehrke CW, Kuo KC, Ehrlich M. Reduced genomic 5-methyl-cytosine content in human colonic neoplasia. Cancer Res. 1988;48:1159-61. (Pubitemid 18075525)
27. Baylin SB, Hoppener JW, de Bustros A, Steenbergh PH, Lips CJ, Nelkin BD. DNA methylation patterns of the calcitonin gene in human lung cancers and lymphomas. Cancer Res. 1986;46:2917-22. (Pubitemid 16074305)
28. Rainier S, Johnson LA, Dobry CJ, Ping AJ, Grundy PE, Feinberg AP. Relaxation of imprinted genes in human cancer. Nature (Lond.). 1993;362:747-9. (Pubitemid 23125977)
29. Byun HM, Wong HL, Birnstein EA, Wolff EM, Liang G, Yang AS. Examination ofIGF2 and H19 loss of imprinting in bladder cancer. Cancer Res. 2007;67(22):10753-8. (Pubitemid 350145902)
30. Bhusari S, Yang B, Kueck J, Huang W, Jarrard DF. Insulin-like growth factor-2 (IGF2) loss of imprinting marks a field defect within human prostates containing cancer. Prostate. 2011;71(15):1621-30.